News

Kikta is expected to augment ClinTec’s US operations and Global HQ management team to offer prospective pharmaceutical, biotech and medical device client’s guidance on their drug development and

The primary efficacy analysis will be conducted using the hybrid American College of Rheumatology, or ACR, score (hACR), which allows for a more comprehensive assessment of treatment benefit

The company has posted a net loss of $19.3m for the year ended 30 June 2010, or $0.83 loss per diluted share, compared to net loss of $22.37m,

SGN-35 is an antibody-drug conjugate (ADC) targeted to CD30. In the trial, 75% of the patients achieved an objective response as assessed by an independent central review, the

Prior to joining Aethlon, Frakes served as the chief financial officer for four public companies over a period of 16 years. Aethlon chief executive officer James Joyce said

The company said that if its AM152 IND got accepted by the FDA, it will be eligible to commence Phase 1 safety studies with the compound in healthy

With the integration of the E-Notebook and SharePoint platforms, CambridgeSoft is expceted to work with Microsoft to extend to other products and delivery platforms including cloud computing. CambridgeSoft

Endo Pharma intends to finance the deal with $500m from its balance sheet, while securing a $300m credit line and tapping an additional $400m financing. Endo Pharma, a

RBC said that this appointment is the result of the step down of Mike Zaleski as RBC’s president and CEO effective 22 October 2010. Prior to joining RBC,